HB810 | Right to Try Law | Texas Stem Cell Law | StemGenex

June 12, 2017

House Bill (HB810) on stem cell therapy has passed in the Texas state legislature and become law. Patients in Texas will now have access to this Right to Try innovative form of therapy for those suffering with debilitating and incurable illnesses.

Rita Alexander, Chief Administrative Officer at StemGenex Medical Group in La Jolla, CA, applauded Texas for this landmark legislation and Republican State Rep. Drew Springer, R-Muenster, who strongly advocated for this bill. She noted that over the past three years, Right to Try advocates in 33 states have helped enact legislation to eliminate obstacles for terminally ill patients seeking treatments that may not be approved by the Food and Drug Administration (FDA).Those advocates are showing considerable momentum in the remaining 17 states, potentially expediting clinical therapies for patients who have limited options with current Texas stem cell laws.

At StemGenex, we are committed to helping people achieve optimum health and better quality of life through the healing benefits of their own stem cells, said Alexander. Specifically, we use adipose-derived adult stem cell therapy for patients battling conditions such as Multiple Sclerosis, Parkinsons disease, COPD, Rheumatoid Arthritis and Osteoarthritis. We are also committed to the science of stem cell therapy and sponsor five clinical outcome studiesregistered with theNational Institute of Health (NIH) for these diseases.

What I personally witnessed before the start of StemGenex were patients who had exhausted conventional medical treatments but wanted to try alternative therapies. I was one of them, suffering from severe Rheumatoid Arthritis. Ihad only three options; I could seek a clinical trial, travel to outside of the U.S. to try alternative therapies such as stem cell treatment or petition the FDA for access to drugs under the agencys expanded access, or compassionate use program. Now, new state laws like the one just passed in Texas, built on model legislation from the Goldwater Institute in Arizona, will allow doctors and patients to make their own informed decisions on treatments that have cleared the safety phase of FDA testing.

Last year, in a move that was seen by some as a response to Right to Try laws, the 21st Century Cures Act, a landmark piece of legislation focused on medical innovation and medical research, was signed into law by President Obama. This Act provides the FDA with the flexibility to accelerate how it evaluates regenerative medicine treatments, such as stem cell therapies, while maintaining its high standards of safety and efficacy.

Were on the cusp of a major change on how patients can access stem cell therapy, saidAlexander. Today, new treatments and advances in research are giving new hope to people affected by a wide range of autoimmune and degenerative illnesses, said Alexander. StemGenex Medical Group is proud to offer the highest quality of care and to potentially help those with unmet clinical needs improve their quality of life.

To find out if you are a candidate for treatment or to learn more about stem cell laws,Call (855) 742-7836to speak with a Patient Advocate or visitwww.StemGenex.com.

Originally posted here:
HB810 | Right to Try Law | Texas Stem Cell Law | StemGenex